glp 1 drugs kidney disease SGLT2 vs GLP-1 for CKD: Which Is Better? Can one drug do it

It requires prescribers and platforms operating in this space to keep pace with a field that is moving quickly, and to ensure that the structured guidance patients need, on exercise, protein, and now potentially on combination pharmacotherapy, is part of the conversation from the outset rather than something patients piece together themselves

Morning dosing is essential

Several studies have reported its antioxidant, anti-inflammatory, and lipid-lowering properties, suggesting potential applications in managing metabolic disorders [3,4,5]

Companies like Novo Nordisk and Eli Lilly are already engaging directly with employers, providing clinical value story evidence and cost-effectiveness data to support coverage decisions